focus -WSS

focus

author：entertainment 2025-09-27 10:00:59 - browse：27

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： What does generative AI mean for health care? We asked experts
Next article： Intermittent fasting comes with a heart risk? Not so fast

Wikipedia

WSS

NIH director takes cautious approach to Biden drug pricing priority

Elizabeth Holmes banned from government health programs

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Why doctors need education on FDA device approval process

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Plastic surgeons increase patient psychiatric screenings

explore

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

In Memoriam: Notable people who died in 2023

Copay coupons to count toward deductibles, after Biden court move

Novavax promises a turnaround & Lilly roils the obesity market

Nurses recount patients attacks

DIEP, the 'gold standard' of breast reconstruction, is under threat

Neuroscience’s long legacy of racism

What does generative AI mean for health care? We asked experts

How digital therapeutics firms are pivoting after Pear's bankruptcy

Wikipedia

Think you might have Covid

The surgeon had a dilemma only a Nazi medical text could resolve

Baby aspirin cuts fat buildup in liver disease patients, in small study

Nurses recount patients attacks

eGenesis tests gene

Prior authorization will have to move faster under new Biden rule

explore

focus

Wikipedia

explore